Latest Intelligence on Medical Devices and Diagnostics

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

eCommerce: 64% of small online medical device suppliers to fail

Published By Datamonitor
31 Aug 2001
ResearchWire
ResearchWire

European spine market: slow growth to 2003

Published By Datamonitor
30 Jul 2001
ResearchWire
ResearchWire

French hip implants: metal-on-metal to rock the market

Published By Datamonitor
20 Jul 2001
ResearchWire
ResearchWire

German hip implants: ceramic-on-ceramic to take quarter of market

Published By Datamonitor
03 Jul 2001
CommentWire
CommentWire

Guidant: bidding war continues

In the latest twist in the Guidant takeover saga, Boston Scientific has made a revised $27.2 billion offer, which Guidant's board has concluded to be superior to Johnson & Johnson's rival bid. However, although this tips the scales in Boston Scientific's favor, there is still time for J&J to deliver the final blow.

Published By Datamonitor
18 Jan 2006
CommentWire
CommentWire

Hip implants: second recall in nine months

Published By Datamonitor
20 Sep 2001
ResearchWire
ResearchWire

Hip replacements: US to remain top for procedures

Published By Datamonitor
15 Mar 2002
CommentWire
CommentWire

HIV: test results in minutes

A major objective of effective HIV management is widespread and rapid diagnosis. A 10-minute test developed by Trinity Biotech [TRIB] has recently gained approval for use in the US. The test may represent a breakthrough in the battle to develop a low cost, rapid and simple kit format that can be utilized in both the developed and developing world.

Published By Datamonitor
06 Jan 2004
Expert View
Expert View

Intel's health guide puts telehealth in the spotlight

Intel has entered the healthcare market in full force with the announcement of its Intel Health Guide product. However, a closer look at the 'personal health system' reveals it to be something of a disappointment. Although Intel's entrance into the telehealth space will bring much needed attention to the emerging technology, the company's success in this competitive new arena remains to be seen.

Published By Datamonitor
13 Nov 2008
CommentWire
CommentWire

J&J: innovative pain relief

With J&J's [JNJ] Duragesic transdermal fentanyl patch losing patent protection in 2004 and the threat of generic competition from 2005, the launch of the innovative E-TRANS fentanyl PCTS later this year will help offset some of the predicted decline in Duragesic sales.

Published By Datamonitor
19 Mar 2004

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.